Skip to content
  • Facebook
  • Twitter
  • linkedin
Open Access Publisher of Medical and Social Science Journals
Openventio Publishers
  • Home
  • About us
    • Vision/Mission
    • Open Access
    • Editorial Assessment and Peer Review Process
  • Journals
  • Editorial Guidelines
    • For Authors
    • For Editors
    • For Reviewers
    • For Readers
    • For Librarians
  • Submit Manuscript
  • Contact Us
  • More
    • Advertisement
    • Reprints
    • Privacy Policy
    • FAQs
Home
/
journal-index
/
Diabetes Research – Open Journal (DROJ)
/
Archive-droj

Volume 6

September, 2020

Volume 6, Issue 1

[ Download PDF ]

Volume 5

May, 2019

Volume 5, Issue 1

[ Download PDF ]

Volume 4

November, 2018

Volume 4, Issue 1

[ Download PDF ]

Volume 3

December, 2017

Volume 3, Issue 2

[ Download PDF ]

February, 2017

Volume 3, Issue 1

[ Download PDF ]

Volume 2

October, 2016

Volume 2, Issue 2

[ Download PDF ]

August, 2016

Volume 2, Issue 1

[ Download PDF ]

Volume 1

October, 2015

Volume 1, Issue 4

[ Download PDF ]

July, 2015

Volume 1, Issue 3

[ Download PDF ]

May, 2015

Volume 1, Issue 2

[ Download PDF ]

January, 2016

Volume 1, Issue 5

[ Download PDF ]

April, 2015

Volume 1, Issue 1

[ Download PDF ]

×

Article in press

  • 2020, November

    research protocol

    Coronavirus Disease-2019, Diabetes and Dialysis: An Internal Medicine Conundrum Proposal for a Suitable and Easy-to-Handle Prevention ProtocolOpen Access

    Felice Strollo, Ersilia Satta, Carmine Romano, Carmelo Alfarone, Teresa D. Corte*, Giuseppina Guarino and Sandro Gentile
    DOI: http://dx.doi.org/10.17140/DROJ-6-147
    Provisional PDF503.80 KB 503.80 KB
    Full-Text (HTML)
    Abstract [+]

    Background
    Frail populations burdened with chronic diseases can get more severe forms of coronavirus disease-2019 (COVID-19) and have a higher mortality rate.
    Aim
    To test the efficacy of a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) containment protocol in patients with endstage renal disease (ESRD) diabetes mellitus (DM) requiring dialysis, who are a typical example of the above category.
    Methods
    The protocol included: (i) daily telephone COVID-19 related triage for patients and their general practitioners (GPs); (ii) social distancing; (iii) environment sanitization, including ambulances, transfer vans, medical equipment, patient/health personnel clothing, and individual protection devices; (iv) adoption of quota systems for patients allowed to the dialysis room, and increased time lags among dialysis shifts. Eight hundred twenty-five (825) patients on dialysis (315 with and 510 without DM), and 381 healthcare providers (HCPs) were monitored continuously from the start of the pandemic until the end of the lockdown.
    Results
    No HCPs were infected, while only two patients on dialysis were positive for SARS-CoV-2: one with DM, who died in intensive care, and one without DM, who recovered at home. The adopted contagion containment protocol proved to be effective for both HCPs and patients.
    Conclusion
    Therefore, we propose it as a useful model for any internal medicine or ESRD specialized units dealing with patients on dialysisoriented with or without DM.
    Keywords
    COVID-19, Dialysis, Diabetes, Prevention, Contagion.


  • 2020, December

    research protocol

    Coronavirus Disease-2019, Diabetes and Dialysis in Southern Italy: The Second Wave Follow-upOpen Access

    Felice Strollo, Ersilia Satta, Carmine Romano, Carmelo Alfarone, Teresa Della Corte*, Giuseppina Guarino, Maria Pasquarella and Sandro Gentile
    DOI: http://dx.doi.org/10.17140/DROJ-6-148
    Provisional PDF593.61 KB 593.61 KB
    Full-Text (HTML)
    Abstract [+]

    Background
    After the official coronavirus (severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)) pandemic declaration by the World Health Organization (WHO), Italy had the second-largest number of confirmed cases, after China. The Italian government introduced progressive infection-mitigation measurements, thus dramatically reducing social interactions and preventing virus spread. During the summer, infection containment measures progressively loosened until, due to an unjustified interpretation of some permissions and the excessive utilization of public transportation at school reopening, the contagion rate progressively increased until causing a severe challenge for our National Health Service (NHS) again.
    Aim
    To assess the efficiency of our previously described protocol in 18 Campania region-located Nefrocenter Consortium dialysis centers (DCs) as further adapted to new knowledge under the new ubiquitous contagion conditions and to identify SARS-CoV-2-infection mortality rate and risk factors.
    Methods
    381 HCP members underwent regular monitoring on April 1 and November 13, 2020. Dialysis patients did so too during that period according to the expected shifting prevalence over time (mean±SD:853±30 per month; range 825 to 873) vs (11.8% in April, and 14.8% in November vs. a pre-coronavirus disease-2019 (COVID-19) 12.0% rate in January).
    Results
    More patients got infected in November (10.19%) than in April (0,24%), and 22 patients of the 89 from the SARS-CoV-2 November positive subjects required hospitalization for moderate-severe symptoms (24.72%), with death unavoidably coming in 19 (86.36% of hospitalized and 21.35% of infected patients) compared to the only one recorded in April (0.12%). The pandemic’s two periods
    showed a strong association between mortality rate and often co-existing comorbidities, primarily represented by arterial hypertension, type 2 diabetes mellitus (T2DM), and chronic kidney disease (CKD).
    Conclusion
    The previously efficient contagion containment measures adopted by our DCs were not enough in November to fight the global infection risk pending on the whole Italian social community around. The author, discuss possible reasons and put forward further suggestions for the best handling of any future infection waves.
    Keywords
    COVID-19; Dialysis; Diabetes; Prevention; Contagion; COVID second round.


NOTE: The DOIs of the In-Press Articles will only function after the final publication of the articles and once they are uploaded to the Current Issues.
×

Current Issue

  • 2019, June

    original research

    Antihyperglycemic Mechanisms of Allium sativum, Citrus sinensis and Persea americana Extracts: Effects on Inhibition of Digestive Enzymes, Glucose Adsorption and Absorption on Yeast Cells and Psoas MusclesOpen Access

    Boris Gabin Kingue Azantsa*, Guy Roussel Takuissu, Etienne Junior Tcheumeni, Martin Fonkoua, Edwige Ruth Kemadjou Dibacto, Judith Laure Ngondi and Julius Enyong Oben
    DOI:
    PDF583.28 KB 583.28 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    Mechanisms by which some plants with antihyperglycemic effects reduce postprandial hyperglycemiaare not fully elucidated. This study was designed to investigate some action mechanisms of extracts from stem bark of Citrus sinensis, seeds of Persea americana and bulbs of Allium sativum including in vitro inhibition of α-amylase and invertase; glucophagic capacity, absorption capacity on yeast cells and psoas tissues.


  • 2020, May

    editorial

    Recent Tendency of Therapeutic Medical Agents for Diabetic Peripheral Neuropathic PainOpen Access

    Hiroshi Bando*
    DOI:
    PDF327.50 KB 327.50 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    Recently, elder patients tend to have neuropathic pain such as lower back and joints pain, stiff shoulders, besides diabetic neuropathy. Typical peripheral neuropathic pain includes diabetic peripheral neuropathic pain (DPNP), postherpetic neuralgia (PHN) and chronic pain due to herniated disc. Three analgesic agents are described. Pregabalin (Lyrica®) has been prevalent worldwide. However, it has been provided for several diseases for off-label administration, which has been one of the clinical problems.Mirogabalin (Tarlige®) has revealed efficacy for DPNP in a dose-dependent manner. Duloxetine hydrochloride (Cymbalta®) has efficacy for pain and also depression as serotonin and noradrenaline reuptake inhibitor (SNRI).

    Keywords

    Neuropathic pain; Pregabalin; Mirogabalin; Duloxetine hydrochloride; Diabetic peripheral neuropathic pain (DPNP).

    Abbreviations

    DPNP: Diabetic peripheral neuropathic pain; PHN: Postherpetic neuralgia; CRPS: Complex regional pain syndrome; FDA: Food and Drug Administration.


  • 2020, May

    case report

    Profile of Blood Glucose in Diabetic Patient Suffered from Diabetic Foot Osteomyelitis with Effective Low Carbohydrate DietOpen Access

    Hiroshi Bando*, Yoshiro Abe,Kazuki Sakamoto, Shigeki Hatakeyama, Keisuke Yagi, Toshiharu Kobayashi, Tomoya Ogawa, Noboru Iwatsuki, Mitsuru Itagaki, Kaori Ashikaga and Yukari Matsumoto
    DOI:
    PDF452.06 KB 452.06 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    The case was 52-year-old female with type 2 diabetes mellitus (T2DM) for 10-years. She complained of the decreased sensation of right lower foot, and revealed diabetic foot infection (DFI) and/or diabetic foot osteomyelitis (DFO) at right 1st proximal phalanx. Various data included body mass index (BMI) 33.3 kg/m2, HbA1c 11.4%, blood glucose 430 mg/dL, WBC 12100 /μL, C-reactive Protein (CRP) 13.5 mg/dL. On admission (day 1), she was started by 4 times of injection (Aspart and Glargin) with glucose profile 200-500 mg/dL. Surgical amputation of the right toe was performed between 1st metatarsal and proximal phalanx (day 17). Then, blood glucose profile decreased moderately. After discharge of the hospital, super-Low Carbohydrate Diet (LCD) was started without Aspart (day 37). Consequently, glucose profile was normalized with HbA1c 6.3% on (day 77). Consequently, LCD was evaluated to be effective for glucose variability in this case and some related discussion was described.

    Keywords

    Diabetic foot infection (DFI); Diabetic foot osteomyelitis (DFO); Low Carbohydrate Diet (LCD); Japanese LCD promotion association (JLCDPA); International Working Group on the Diabetic Foot (IWGDF).

    Abbreviations

    DFI: Diabetic foot infection; DFO: Diabetic foot osteomyelitis; LCD: Low carbohydrate diet; JLCDPA: Japanese LCD promotion association; IWGDF: International Working Group on the Diabetic Foot.


  • 2020, July

    case report

    Deep Venous Thrombosis in an Amputated Limb Stump of a Diabetic Patient: A Case ReportOpen Access

    Taoreed A. Azeez*, Arionola Esan and Taiwo R. Kotila
    DOI:
    PDF293.90 KB 293.90 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    Deep venous thrombosis (DVT) in an amputated stump is potentially life-threatening but rarely diagnosed and there are limited data in sub-Saharan Africa. This is aimed at demonstrating an additional vascular risk in patients with lower limb amputation and diabetes. A 74-year-old man who had a right above knee amputation done on account of grade 5 right diabetic foot with post-operative prophylactic anticoagulation. Doppler ultrasound done before the surgery showed bilateral multiple lower limb arteries atherosclerosis but no evidence of deep venous thrombosis. He was discharged home on Zimmer frame. Three months after, he was noticed to have differential swelling of the right amputation stump. Thigh circumference measured at 15 cm below the anterior superior iliac spine was 55 cm and 50 cm on the right and left respectively there was but no differential warmth or tenderness. The vital signs were relatively stable. Doppler ultrasound scan of the lower limbs showed an echogenic thrombus in the right deep femoral vein. He was commenced on therapeutic dose of subcutaneous enoxaparin. DVT in an amputated stump is uncommonly encountered. It may not have classical clinical findings. Poor mobility and pooling of venous blood in the amputated stump are some of the risk factors that have been reported. DVT in an amputated stump in a patient with diabetes is rare and may not present classically. It may be one of the potential reasons for the increased mortality after lower limb amputation.
    Keywords
    Deep venous thrombosis (DVT); Amputated stump; Diabetes patient.


  • 2020, September

    mini review

    The Interrelationship of Menopause and Type 2 Diabetes MellitusOpen Access

    Tejal Lathia* and Sanjay Kalra
    DOI:
    PDF342.71 KB 342.71 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    Menopause is a critical time in a woman’s life which heralds the cessation of reproductive competence. There is body fat redistribution which increases the risk of type 2 diabetes mellitus (T2DM). There is a complex interrelationship between menopause and T2DM; several variables like the timing of the menopause, the type of menopause and the symptomatology impact this relationship. The treatment of vasomotor symptoms with hormone replacement therapy may also impact glycemia both in women with and without pre-existing T2DM. We tried to examine this relationship based on current scientific evidence. We also suggested strategies
    to reduce the burden of T2DM in menopausal women.
    Keywords
    Menopause; T2DM; Hormone replacement therapy.


×

Previous Issue

  • 2019, June

    original research

    Rationale Diagnostic Criteria of the Metabolic SyndromeOpen Access

    Makiko Nakade, Akemi Morita, Shaw Watanabe*, Naomi Aiba and Motohiko Miyachi.
    DOI: http://dx.doi.org/10.17140/DROJ-5-139
    PDF450.42 KB 450.42 KB
    Full-Text (HTML)

  • 2019, June

    systematic review based hypothesis

    Fatty Acid Escape Hypothesis: The Pathway to Type-2 DiabetesOpen Access

    AbdulRahman Hamid Musleh Ali, Wesam Al-Kassas and Khawaja Husnain Haider*
    DOI: http://dx.doi.org/10.17140/DROJ-5-140
    PDF712.13 KB 712.13 KB
    Full-Text (HTML)

  • 2019, June

    original research

    Hereditary Contribution Towards Development of Type 2 Diabetes Mellitus among Indian PopulationOpen Access

    Nilupher Feroz, Meenal Dhall* and Satwanti Kapoor.
    DOI: http://dx.doi.org/10.17140/DROJ-5-141
    PDF497.53 KB 497.53 KB
    Full-Text (HTML)

  • 2019, June

    editorial

    Rice Function for Disease Prevention and Establishment of Medical Rice AssociationOpen Access

    Shaw Watanabe*.
    DOI: https://dx.doi.org/10.17140/DROJ-5-e013
    PDF351.99 KB 351.99 KB
    Full-Text (HTML)

  • 2019, June

    editorial

    Latent Autoimmune Diabetes in Adults (LADA) in Recent Clinical PracticeOpen Access

    Hiroshi Bando*.
    DOI: http://dx.doi.org/10.17140/DROJ-5-e014
    PDF329.97 KB 329.97 KB
    Full-Text (HTML)

  • 2019, June

    case report

    Effect of Music Therapy as an Adjunct in Management of Diabetic Foot UlcerOpen Access

    Shijina K, Ravi K. Chittoria*, Vinayak Chavan, Abhinav Aggarwal, Saurabh Gupta, Chirra L. Reddy, Padmalakshmi Bharathi Mohan, Imran Pathan and Praveen R.
    DOI: http://dx.doi.org/10.17140/DROJ-5-142
    PDF345.84 KB 345.84 KB
    Full-Text (HTML)

    • Home
    • Authors Instructions
    • Submit Manuscript
    • Reviewer Registration
    • Contact Us
    • Editorial Panel
    • Article in press
    • Current issue
    • Previous issue
    • Archive
    • Archive

    Connect with us



    Editor-in-Chief

    Shaw Watanabe, MD, PhD

    President Life Science Promotion Foundation 25-3-1004, Daikyo-cho, Shinjuku-ku Tokyo 160-0005, Japan

    Associate Editors

    Stephen I-Hong Hsu, MD, PhD

    Chief Executive Officer Chief Scientific Officer Prometheon Pharma, LLC Sid Martin Biotechnology Incubator University of Florida 10285 Research Drive Alachua, FL 32615, USA

    Takashi Nomiyama, MD, PhD

    Associate Professor Department of Endocrinology and Diabetes Mellitus School of Medicine Fukuoka University 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan  

    Our editorial team


    Advertisement

    About Openventio

    Openventio Publishers is licensed under a Creative Commons Attribution 4.0 International License.
    based on the work at www.openventio.org

    Quick Links
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement
    Find Us

    Suite#B013, Nexus Business Center
    Block-B, Level 2, Road no. 3
    Film Nagar, Hyderabad
    Telangana State, India

    Openventio Publishers
    • Facebook
    • Twitter
    • linkedin
    © 2014 - 2021 Openventio Publishers. All Rights Reserved.
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement